期刊文献+

冠心病患者血浆抵抗素水平检测 被引量:1

Detection of plasma resistin level in patients with coronary heart disease
下载PDF
导出
摘要 目的:探讨冠心病患者血浆抵抗素水平变化及其临床意义。方法:研究对象88例,经冠状动脉造影证实,稳定型心绞痛(SAP)31例,不稳定型心绞痛(UAP)23例,急性心肌梗死(AMI)19例,冠脉造影正常15例。应用ELISA方法测定各组空腹血浆抵抗素、IL-6、血脂水平。结果:正常对照组、SAP组、UAP组及AMI组血浆抵抗素水平依次增高(F=101.39,P<0.05)。冠心病患者抵抗素水平与IL-6、apo-B和血糖呈正相关(r分别为0.90,0.29,0.49,P均<0.05),与HDL-C、apo-A1呈负相关(r分别为-0.37,-0.32,P均<0.01)。结论:抵抗素可能通过参与炎症反应和影响血脂代谢在冠心病的发生发展中起作用。 Aim: To assess the association between plasma resistin level and coronary heart disease (CHD), Methods :A total of 88 in-patients who received coronary angiography were allocated into 4 groups: normal control group (n = 15 ) , stable angina pectoris(SAP) group( n = 31 ) , unstable angina pectoris(UAP) group( n = 23 ) , acute myocardial infarction(AMI) group( n = 19), The fasting plasma resistin and interleukin-6 (IL-6) were examined by ELISA, blood lipids were measured at the same time. Results :The plasma resistin level of the normal control,SAP,UAP,AMI group increased by turn ( P 〈 0. 05). Correlated analysis demonstrated that the fasting plasma resistin level was positively correlated with the plasma levels of IL-6, apoprotein-B and blood glucose ( r was 0, 90,0, 29,0, 49, respectively, P 〈 0, 05 ) ; but it was neg- atively correlated with high-density lipoprotein cholesterol (HDL-C) and apo-A1 ( r was - 0, 37, - 0, 32, respectively, P 〈 0.01 ), Conclusion: Resistin,partieipating in inflummatory reaction and affecting metabolism of bood lipids, may be playing a role in development and aggravation of CHD,
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第4期763-765,共3页 Journal of Zhengzhou University(Medical Sciences)
关键词 冠心病 抵抗素 炎症 血脂 coronary heart disease resistin inflammation lipids
  • 相关文献

参考文献12

  • 1Yaturu S, Daberry RP, Rains J, et al. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes[ J]. Cytokine, 2006,34(3/4) :219.
  • 2Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronory syndrome: a three-vessel inravascular ultrasound study. Circulation, 2002, 106 (7) :804.
  • 3Steppan CM, Bailey ST, Bhat S,et al. The hormone resistin links obesity to diabetes[J]. Nature,2001,409(6 816):307.
  • 4Fukui Y,Motojima K. Expression of resistin in the adipose tissue is modulated by various factors including peroxisome pmliferator-activated receptor alpha [ J ]. Diabetes Obes M etab, 2002,4 ( 5 ) :342.
  • 5Patel L, Buckels AC, Kinghorn I J, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators [ J ]. Bioehem Biophys Res Commun ,2003 ,300 (2) :472.
  • 6Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans [ J ]. Circulation ,2005,111 (7) :932.
  • 7Mu H, Ohashi R,Yan S, et al. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells [ J ]. Cardiovasc Res ,2006,70( 1 ) : 146.
  • 8Calabro P, Samudio I, Willerson JT, et al. Resistin promotes smooth muscle cell proliferation through activation of extracelular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways [ J ]. Circulation ,2004,110 ( 21 ) : 3 335.
  • 9Rothwell SE, Richards AM, Pemberton CJ. Resistin worson cardiacischaemia-reperfusion injury [ J ]. Biochem Biophys Res Commun ,2006,349 ( 1 ) :400.
  • 10Lubos E, Messow CM, Schnabel R, et al. Resistin, acute coronary syndrome and prognosis results from the Athero- Gene study[ J]. Atherosclerosis ,2007,193 ( 1 ) : 121.

同被引文献5

  • 1Verma S, LI SH, Wang CH, et al. Resistin promotes endothelial cell activation: luther evidence of adipokin - endothelial interaction [J].Circulation ,2003,108:736-740.
  • 2Amasyali B, Kilic A, Celik T, et al. A new frame in thromboembolic cardiovascular disease : Adipocytokine[J].Int J Cardiol,2008 : 22.
  • 3Lubos E, Messow CM, Schnabel R, et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study [ J ]. Atherosclerosis ,2007,193 ( 1 ) : 121 - 128.
  • 4Piestrzeniewicz K, Luczak K, Goch JH. Value of blood adipose tissue hormones concentration - - adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1 - year follow - up after primary percutaneous coronary intervention in ST - segment elevation acute myocardial infarction [ J ]. Neuro Endocrinol Lett, 2008,29(4) :581-588.
  • 5Weikert C,Westphal S, Berger K, et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke [J].J Clin Endocrinol Metab,2008,93(7) :2 647-2 653.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部